Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of SAR341402 to NovoLog in Diabetes Mellitus
NCT03211858Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2017
- Primary completion
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 7
01
Overview
A Phase 3 trial of insulin aspart in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Aug 2017; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03211858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03211858.